Brief: Galderma Says Arbitral Trubunal Confirmed Termination Of Partnership With Ipsen

Galderma AG

21/01/2026 16:39

Jan 21 (Reuters) - GALDERMA GROUP AG GALD.S:

PROVIDES UPDATE ON ARBITRATION CASE REGARDING NEUROMODULATOR RESEARCH AND DEVELOPMENT PARTNERSHIP

DECISION DOES NOT IMPACT GALDERMA'S NEUROMODULATOR COMMERCIALIZATION

TO CONTINUE SUPPLYING DYSPORT, AZZALURE, ALLUZIENCE, RELFYDESS

INTERNATIONAL CHAMBER OF COMMERCE ARBITRAL TRIBUNAL ISSUED AN AWARD CONFIRMING TERMINATION OF A 2014 PARTNERSHIP WITH IPSEN

Source text: ID:nBw7D1G65a

Further company coverage: GALD.S

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com ; +48 587785269;;))